<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A variety of carcinogens, in particular smoking, <z:e sem="disease" ids="C0085762" disease_type="Mental or Behavioral Dysfunction" abbrv="aca">alcohol abuse</z:e> and <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e>, are associated with an increased risk for the development of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> of the upper gastrointestinal tract </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e> prevention should start here, in particular since cessation of <z:chebi fb="164" ids="18723">nicotine</z:chebi> abuse, only moderate consumption of alcohol, and <z:hpo ids='HP_0001824'>weight loss</z:hpo> also have other positive effects on health </plain></SENT>
<SENT sid="2" pm="."><plain>Where the indication is appropriate, H. pylori eradication, vaccination against <z:hpo ids='HP_0012115'>hepatitis</z:hpo> B and avoidance of exposure to <z:hpo ids='HP_0012115'>hepatitis</z:hpo> are well-founded prophylactic measures </plain></SENT>
<SENT sid="3" pm="."><plain>Further screening measures make good sense only in high-risk groups, and are based on recommendations </plain></SENT>
<SENT sid="4" pm="."><plain>It has, however, not yet been demonstrated that the screening of patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, liver <z:hpo ids='HP_0001394'>cirrhosis</z:hpo>, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0012115'>hepatitis</z:hpo> or gastric risk diseases actually can lower <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-related <z:hpo ids='HP_0011420'>deaths</z:hpo> </plain></SENT>
</text></document>